Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Mallinckrodt
Teva
Medtronic
Fuji
Deloitte
McKesson
Harvard Business School
Dow

Generated: May 20, 2018

DrugPatentWatch Database Preview

SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Sulfacetamide Sodium And Prednisolone Sodium Phosphate, and what generic alternatives are available?

Sulfacetamide Sodium And Prednisolone Sodium Phosphate is a drug marketed by Bausch And Lomb and Sandoz Inc and is included in two NDAs.

The generic ingredient in SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.
Summary for SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
Drug patent expirations by year for SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
Pharmacology for SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE

US Patents and Regulatory Information for SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate; sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 074449-001 Dec 29, 1995 AT RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate; sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 073630-001 May 27, 1993 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cerilliant
Cipla
US Army
Cantor Fitzgerald
Baxter
Julphar
Accenture
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.